| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 0.956 | 6 | 0 | 1994 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.300 | None | 0.935 | 3 | 0 | 1996 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.300 | None | 0.929 | 1 | 0 | 1999 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
phenotype | 0.250 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.220 | None | 1.000 | 2 | 0 | 2002 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1987 | 2018 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.250 | None | 0.833 | 1 | 0 | 1999 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
phenotype | 0.240 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2011 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
phenotype | 0.540 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1992 | 2013 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 2011 | 2013 |